Literature DB >> 6125187

Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

R E Rangno, S Langlois.   

Abstract

1 After abrupt propranolol withdrawal a rebound increase in cardiac sensitivity to isoprenaline occurred in 9/9 patients and persisted up to 14 days. A mild brief rebound in resting heart rate occurred in 4/9 patients and a rebound in blood pressure occurred in 6/9 patients. These withdrawal phenomena were prevented by gradual withdrawal on a prolonged small dose of propranolol. 2 After abrupt metoprolol withdrawal a rebound increase in cardiac sensitivity to isoprenaline occurred in 8/8 patients but had resolved by 8 days. A marked persistent rebound in resting heart rate occurred in 8/8 patients while a small brief rebound in blood pressure occurred in only one patient. These withdrawal phenomena were largely prevented by gradual withdrawal on a prolonged small dose of metoprolol. 3 After abrupt pindolol withdrawal there was no rebound in isoprenaline sensitivity but a mild brief rebound in resting heart rate occurred in 9/10 patients. There was no rebound in blood pressure. 4 The type, magnitude and frequency of withdrawal phenomena after various beta-adrenergic receptor blockers probably reflects substantial differences in their basic pharmacological characteristics. 5 Caution must be exercised when withdrawing any patient from any beta-adrenoceptor blocker since an adverse cardiac event is unpredictable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125187      PMCID: PMC1402152          DOI: 10.1111/j.1365-2125.1982.tb01939.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  In vitro study of beta-adrenergic receptors.

Authors:  B B Wolfe; T K Harden; P B Molinoff
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Elevated beta-adrenergic receptor number after chronic propranolol treatment.

Authors:  G Glaubiger; R J Lefkowitz
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

3.  Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy.

Authors:  S P Galant; L Duriseti; S Underwood; P A Insel
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

4.  Acute coronary syndromes following abrupt cessation of oral propranolol therapy.

Authors:  H F Mizgala; J Counsell
Journal:  Can Med Assoc J       Date:  1976-06-19       Impact factor: 8.262

5.  Propranolol and polythiazide in treatment of hypertension.

Authors:  E T O'Brien; J MacKinnon
Journal:  Br Heart J       Date:  1972-10

6.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

7.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

8.  Propranolol withdrawal.

Authors:  S Nattel; J Shanks; R E Rangno
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

9.  Propranolol withdrawal syndrome - why?

Authors:  D G Shand; A J Wood
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

10.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

View more
  12 in total

Review 1.  Effect of partial compliance on cardiovascular medication effectiveness.

Authors:  Joyce A Cramer
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

Review 2.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

3.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.

Authors:  K S Kiyingi; J Shaw
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

7.  Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure.

Authors:  Wanzhu Tu; Andrew B Morris; Jingjin Li; Jingwei Wu; James Young; D Craig Brater; Michael D Murray
Journal:  Clin Pharmacol Ther       Date:  2005-03       Impact factor: 6.875

Review 8.  Antianginal actions of beta-adrenoceptor antagonists.

Authors:  Stephen T O'Rourke
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

9.  Effect on heart rate over 24 hours of pindolol administered for 14 days.

Authors:  J P Kantelip; J F Trolese; P G Cromarias; P Duchêne-Marullaz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Gaps in cardiovascular medication taking: the tip of the iceberg.

Authors:  P Rudd; J Ramesh; C Bryant-Kosling; D Guerrero
Journal:  J Gen Intern Med       Date:  1993-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.